• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.66% Nasdaq Down 1.05%

    Cara Therapeutics Inc. (CARA)

    -NasdaqGM
    19.01 Up 0.08(0.42%) Sep 4, 4:00PM EDT
    Add to Portfolio
    Prev Close:18.93
    Open:18.68
    Bid:17.01 x 100
    Ask:24.02 x 100
    1y Target Est:29.20
    Beta:1.212
    Earnings Date:Nov 9 - Nov 13 (Est.)
    Day's Range:18.31 - 19.33
    52wk Range:7.53 - 23.61
    Volume:208,144
    Avg Vol (3m):463,342
    Market Cap:516.40M
    P/E (ttm):N/A
    EPS (ttm):-0.93
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CARA

    Comparison

    Symbol% ChgMkt Cap
    CARAUp 0.42%516.40M
    PTIE 0.00%84.19M
    ABTDown 2.42%64.19B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):151.15
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.03
    Quarterly EPS Est (Sep-15) :-0.26
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Cara Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing chemical entities designed to alleviate pain by selectively targeting kappa opioid receptors. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback